@article{10.1371/journal.pone.0048503, doi = {10.1371/journal.pone.0048503}, author = {Fredebohm, Johannes AND Boettcher, Michael AND Eisen, Christian AND Gaida, Matthias M. AND Heller, Anette AND Keleg, Shereen AND Tost, Jörg AND Greulich-Bode, Karin M. AND Hotz-Wagenblatt, Agnes AND Lathrop, Mark AND Giese, Nathalia A. AND Hoheisel, Jörg D.}, journal = {PLOS ONE}, publisher = {Public Library of Science}, title = {Establishment and Characterization of a Highly Tumourigenic and Cancer Stem Cell Enriched Pancreatic Cancer Cell Line as a Well Defined Model System}, year = {2012}, month = {11}, volume = {7}, url = {https://doi.org/10.1371/journal.pone.0048503}, pages = {1-14}, abstract = {Standard cancer cell lines do not model the intratumoural heterogeneity situation sufficiently. Clonal selection leads to a homogeneous population of cells by genetic drift. Heterogeneity of tumour cells, however, is particularly critical for therapeutically relevant studies, since it is a prerequisite for acquiring drug resistance and reoccurrence of tumours. Here, we report the isolation of a highly tumourigenic primary pancreatic cancer cell line, called JoPaca-1 and its detailed characterization at multiple levels. Implantation of as few as 100 JoPaca-1 cells into immunodeficient mice gave rise to tumours that were histologically very similar to the primary tumour. The high heterogeneity of JoPaca-1 was reflected by diverse cell morphology and a substantial number of chromosomal aberrations. Comparative whole-genome sequencing of JoPaca-1 and BxPC-3 revealed mutations in genes frequently altered in pancreatic cancer. Exceptionally high expression of cancer stem cell markers and a high clonogenic potential in vitro and in vivo was observed. All of these attributes make this cell line an extremely valuable model to study the biology of and pharmaceutical effects on pancreatic cancer.}, number = {11}, }